The vasopressin V2-receptor antagonist, tolvaptan, can not only induce aquaresis but also enhance natriuresis in heart failure patients refractory to loop diuretics
2013 ◽
Vol 34
(suppl 1)
◽
pp. P3338-P3338
◽
2006 ◽
Vol 108
(2)
◽
pp. 231-236
◽
2000 ◽
Vol 16
(3)
◽
pp. 203-216
◽
2018 ◽
Vol 33
(suppl_1)
◽
pp. i64-i65